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Purpose: To investigate changes in protein profiles of posterior sclera in guinea pigs during development of form
deprivation myopia and recovery.
Methods: Three groups of guinea pigs (developing form deprivation myopia, recovering from the myopia and normal
control) were evaluated for protein profiles of the posterior sclera using two-dimensional gel electrophoresis. Protein spots
with a different intensity of at least threefold among the 3 groups were further identified with mass spectrometry. Key
proteins associated with ocular growth (crystallins) were examined at mRNA levels using RT–PCR.
Results: Moderate myopia was induced at 7 weeks of monocular deprivation and then more gradually recovered toward
the previous refractive status 4 days after re-exposure of the eye to normal visual conditions. The profile of all protein
spots at the posterior sclera was similar for both the deprived and the recovery eyes but distinct between either of the 2
experimental eyes and the normal control eyes. Twenty-six and 33 protein spots were differentially expressed in the
deprived and the recovery eyes, respectively, compared to the normal control eyes. In contrast, the number of proteins
differentially expressed between the deprived and the recovery eyes was only 5. Among the different subtypes of
crystallins, βB2-crystallin was down-regulated and βA4-crystallin was upregulated in the deprived eyes at both protein
and mRNA levels compared to the normal control eyes. The trend of expression for βA3/A1-crystallin was also similar
at both mRNA and protein levels for the deprived eyes. However, αA-crystallin mRNA in the recovery eyes was
upregulated while αA-crystallin itself was down-regulated. A similar inconsistency in expression of βA3/A1-, βA4-, and
βB2-crystallins between the protein and mRNA levels also occurred in the recovery eyes.
Conclusions: Proteomic analysis provides a useful survey of the number of proteins whose levels change during form
deprivation myopia and the subsequent recovery. In particular, the crystallins changed during the development of form
deprivation myopia and recovery. The changes in crystallin protein levels were consistent with that in mRNA levels during
the development stage of form-deprivation myopia (FDM). However, the changes in most crystallin protein levels were
mismatched with mRNA levels during the recovery stage.
Myopia is one of the most prevalent ocular conditions
affecting visual acuity, in which images of distant objects are
brought to a focus in front of the retina resulting in blurred
vision. In most of cases the structural cause of myopia is an
excessive axial length of the eye, or more specifically the
excessive  vitreous  length  [1-6].  The  excessive  axial
elongation of the eye, by necessity, must involve the outer coat
of  the  eye,  the  sclera.  The  sclera  is  a  dense,  fibrous,
viscoelastic connective tissue, which in addition to protecting
the  retina  and  allowing  the  attachment  of  the  extraocular
muscles, controls the size of the eye and the location of the
retina relative to the focal plane, and consists of irregularly
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arranged  lamellae  of  collagen  fibrils  interspersed  with
proteoglycans and non-collagenous glycoproteins.
The sclera is not a static container of the eye, but rather
is a dynamic tissue, capable of altering its extracellular matrix
composition and its biomechanical properties in response to
changes in the visual environment to regulate ocular size and
refraction  [7].  High  myopia  is  characterized  by  scleral
thinning and localized ectasia of the posterior sclera. Many
studies  [8-11]  have  demonstrated  scleral  changes  in  both
experimental  myopic  and  clinical  conditions  [1-6].  Some
genes have been found to be closely related to high myopia
such as matrix metalloproteinases [12], PAX-6 (paired box
gene 6) [13,14], myocilin [15], TGF-β1 (transforming growth
factor, beta 1) [16], Collagen type I alpha 1 [17], Rasgrf1 (Ras
protein-specific guanine nucleotide-releasing factor 1) [18],
and GJD2 (gap junction delta-2 protein) [19]. Morphological
changes  result  from  physiologic  changes  and  physiologic
activities  in  a  tissue  are  basically  performed  by  relevant
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2163functional proteins. Therefore, functional proteins in the eye
are directly responsible for ocular morphological changes in
response to any triggering factors. Thus, investigation of the
posterior sclera tissues is necessary to understand mechanisms
involved in the development of form deprivation myopia and
recovery.
During form deprivation in mammals (tree shrews and
primates), the sclera weakens due to increased degradation
and reduced synthesis of extracellular matrices (ECM) and
collagens,  and  an  increased  synthesis  of  matrix
metalloproteinase  and  gelatinase  A  in  the  sclera  [20,21].
These biologic changes are more prominent at the posterior
sclera and are accompanied by axial elongation of the vitreous
chamber [10,20-22], indicating that axial elongation is due to
the weakening of the sclera in mechanical strength. However,
whether the biologic factors found in these studies represent
the entire profile of proteins involved in form deprivation
myopia is yet to be confirmed.
Two-dimensional  gel  electrophoresis  (2-DE)  may
provide a guide for selection of more targeted agents in the
treatment of functional or pathological disorders and therefore
increases the effectiveness of pharmacological manipulation.
Results from human 2-DE show that expression of proteins in
types and levels is very similar for both the anterior and
posterior sclera [23], indicating that functional activities are
similar at different locations of the sclera and this ensures a
symmetric/or  similar  morphology  at  different  sites  of  the
sclera. It has been shown by 2-DE that collagen- regulated
proteins and 78 kDa glucose-regulated protein (GRP 78, a
member  of  the  heat  shock  protein  70  family)  are  down-
regulated in the sclera of tree shrew eyes developing minus
lens-induced myopia [24]. Similar 2-DE results are also found
in  the  retina  of  mouse  eyes  developing  form  deprivation
myopia [25]. However, the functional role of these proteins
during  development  of  the  experimental  myopia  is  still
unclear.
Guinea pigs have been increasingly used as an alternative
to other species in the study of myopic development and
recovery as biometric changes of the guinea pig eye is similar
to  chickens,  tree  shrews  and  monkeys  under  similar
experimental conditions [26-28]. However, changes in protein
profiles  of  various  ocular  components  during  myopic
development and recovery have not been studied in guinea
pigs. This study used 2-DE to investigate protein profiles in
guinea  pig  eyes  during  form  deprivation  and  recovery.
Differential  expression  levels  and  types  of  proteins  in
posterior  sclera  of  the  experimental  eye  were  analyzed
between the experimental and normal control eyes.
METHODS
Experimental design: Forty-eight pigmented guinea pigs (3
weeks old) were randomly assigned to 3 groups (n=16 each
group): MD (monocular deprivation for 7 weeks), recovery
(re-exposure  to  normal  visual  environment  after  7-week
monocular  deprivation)  and  normal  control  (free  of  form
deprivation). A facemask was used to induce form deprivation
myopia [29,30]. The form deprived eyes in the MD group
were used for 2-DE (n=10) and RT–PCR (n=6) after 7 weeks
of form deprivation. All right eyes in the normal control group
were assigned to 2-DE assessment (n=0) and RT–PCR (n=6)
at  the  time  point  matching  that  in  the  MD  group.  In  the
recovery group, the deprived eyes were assessed with 2-DE
(n=10) and RT–PCR (n=6) at 4 days after the eyes were re-
exposed to normal visual environment. Animals underwent
measurements of refraction and vitreous length in all groups
before the experiment, at 7 weeks of the experiment in the
MD, normal control and recovery groups, and at 4 days after
removal of the facemask in the recovery group. All procedures
were approved by the institutional Animal Care and Ethics
Committee  and  all  procedures  complied  with  the  ARVO
statement for the use of animals in ophthalmic research.
Establishment of axial myopia: A latex-made monocularly-
deprived facemask (MDF) covered one eye of the animals to
induce form deprivation myopia. The procedure of wearing
the MDF has been detailed previously [30]. All the animals
were raised on a cycle of 12 h illumination (500 Lux) and 12
h darkness daily during the experimental period.
Biometric measurements: Biometric measurements included
streak retinoscopy, keratometry, ultrasonography, and optical
coherence tomography in that order. These measurements
were performed by a research optometrist with help from an
animal care assistant during the cycle of illumination (day
time). The optometrist was masked with regard to the identity
of  treatment  in  each  group.  No  general  anesthesia  was
necessary for any of the measurement procedures since the
animals were very cooperative.
Retinoscopy: One drop of 1% cyclopentolate hydrochloride
(Alcon, Puurs, Belgium) was topically administered to the eye
every 5 min for 4 times to achieve a completely dilated pupil.
Retinoscopy  for  all  animals  was  performed  by  the  same
optometrist (accuracy: 0.25 D) in a dark room using a streak
retinoscope and trial lenses. The refraction was recorded as
the mean value of the horizontal and vertical meridians [5,
30,31] based on 3 repeated measurements.
Keratometry:  Corneal  curvature  was  measured  with  a
keratometer (OM-4; Topcon, Tokyo, Japan). An 8.00 D lens
was attached onto the anterior surface of the keratometer
during the measurement to magnify the cornea of the guinea
pigs. This allowed readings to be obtained from the steep
cornea of the guinea pigs. A group of stainless steel balls with
diameters from 5.5 to 11.0 mm were measured by the modified
keratometer.  Three  readings  were  recorded  for  each
measurement to provide a mean result. The corneal radius of
curvature in guinea pigs was then deduced from the readings
on the balls with known radii by linear extrapolation [30,32].
Ultrasonography:  A-scan  ultrasonagraph  (Cinescan  A/B;
Optikon 2000; S.P.A, Rome, Italy) was used to measure the
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ultrasound frequency was 11 MHz [30,33]. The conducting
velocity was assumed to be 1,723.3 m/s for measurement of
the lens and 1,540 m/s for measurement of vitreous chambers
[30,32,33]. Topical anesthesia was administered with 0.5%
proparacaine  hydrochloride  (Alcon)  before  the  ultrasound
measurement. The ultrasound probe had direct contact with
the cornea during the axial measurement [34,35]. The tip of
the probe had a red light that facilitated the placement of the
probe to the corneal apex while the probe was perpendicular
to the corneal surface. This perpendicular axis was confirmed
by a series of consistent ultrasound traces when realigned on
the  same  eye  for  repeated  measurements.  A  genuine
measurement was confirmed when clear traces of various
components of the eye with consistent waves and amplitudes
were detected [30,33]. Each of the presented ultrasound data
represented averages from 10 repeated measurements.
Two-dimensional  gel  electrophoresis  and  image  analysis:
The animals were euthanized with an intramuscular injection
of an overdose of pentobarbitone sodium. The eyeballs were
enucleated with the sclera separated from the other tissues
immediately after removal of the cornea. The sclera was then
trimmed taking the posterior section which started 16 mm
from the limbus and then stored in liquid nitrogen at −196 °C.
Prior to 2-DE, the scleral tissue taken from the storage was
placed into 200 μl of solution containing 7 M urea, 2 M
sulfourea, 4% CHAPS and 1 mM PMSF. The solution was
stirred with a glass stirrer, set still for 5 min to achieve a
complete dissolution of the cells, followed by centrifugation
at  4  °C,  12,000×  g  for  20  min.  The  supernatant  (soluble
proteins) of the solution was extracted and quantified by a
modified Bradford assay. The proteins extracted from the
posterior sclera of each group were run on three parallel gels
(triplicate gels). An equal amount of protein from each sample
was loaded onto each gel. Each sample was diluted to a total
volume of 350 μl with a buffer containing 8 M urea, 2%
CHAPS, 20 mM 1,6-dithiothreitol (DTT), 0.5% immobilized
pH gradient (IPG) buffer, and bromophenol blue. Each diluted
sample (125 μl) was loaded on the cathode of an IPG strip (13
cm long, pH 3–10, linear; Amersham Pharmacia Biotech,
Uppsala, Sweden). The rehydrated strip underwent isoelectric
focusing at 20 °C for 11 kVh with a gradually increasing
voltage.
After  isoelectric  focusing,  the  IPG  strips  were
equilibrated for 15 min twice with a solution of 50 mM Tris-
HCL  (pH=6.8),  6M  urea,  30%  glycerol,  2%  sodium
dodecylsulfate  (SDS),  and  10  mg/ml  dithiothreitol  (DDT)
with the DTT replaced by 25 mg/ml iodoacetamide (IAM) in
the second equilibration. The IPG strips were subsequently
transferred onto a vertical slab of 12% SDS-polyacrylamide
gels (8.3 cm×7.3 cm). The sample on each gel was run in the
other  dimension  (based  on  the  molecular  weight  of  the
proteins) for 0.5 h at 2.5 W and then at 15 W until the dye
front reached the gel bottom (Mini-PROTERN3 system; Bio-
Rad,  Hercules,  CA).  Each  gel  was  finally  stained  with
Commassie R-250. The image averaged from 3 gels for each
sample was analyzed by software (PD Quest 2-D Software;
Bio-Rad) to detect differences in expression levels and/or
distribution of the protein spots. A protein spot was confirmed
only when this spot was detected at the same position on at
least two of the triplicate gels, at the same time the image pixel
value was converted to the actual optical density, and the
average optical density of the protein spot was acted as the
synthetic  spot.  Spots  were  considered  to  have  different
expression levels only when the spot had at least a threefold
difference in intensity on at least two of the triplicate gels run
by the same sample.
Trypsin digestion: The protein spots that differed in intensity
and location among the MD, recovery, and normal control
posterior  sclera  were  excised  from  the  gels,  washed  with
50 μl Milli-Q water twice (5 min each), and destained with
50 μl of acetonitrile (ACN)/50 mM NH4HCO3 (1:1, vol/vol)
twice for 30 min each. The samples were dehydrated with
50 μl ACN for 20 min, dried, and reduced with a solution of
25 mM NH4HCO3 containing 10 mM DTT at 56 °C for 1 h.
The  samples  were  then  alkylated  by  25  mM  NH4HCO3
containing  55  mM  iodoacetamide  in  darkness  at  room
temperature for 45 min and washed with 25 mM NH4HCO3,
50%  acetonitrile,  and  100%  acetonitrile  for  10  min,
respectively. Enzymatic digestion was performed by adding
the samples to 0.1 mg/ml trypsin at a final ratio of substrate
to trypsin of 40:1 wt/wt and incubation at 37 °C for 12 h,
followed by termination with 2.5% trifluoroacetic acid (TFA).
Matrix-Assisted Laser Desorption Ionization-Time of Flight
Mass  Spectrometry  (MALDI-TOF):  Samples  digested  by
trypsin (the differential protein spots in posterior sclera among
the MD, recovery and normal control eyes) were mixed with
a-cyano-4-hydroxycinnamic  acid  (2:1,  vol/vol)  in  an
Eppendorf tube. Two microliters of the mixtures were added
to a goldplated sample holder, dried and transferred into the
MALDI-TOF  mass  spectrometer  (Autoflex;  Bruker
Daltonics, Billerica, MA). The monoisotopic peptide masses
were searched based on human cDNA and protein databases
in NCBI (Mascot; Matrix Science Ltd, London, UK) with a
mass accuracy at 50 ppm for the parent ion mass. The proteins
were  identified  functionally  based  on  (1)  the  Molecular
Weight Search (MOWSE) score above the 5% significance
threshold  from  the  database  (Molecular  Weight  Search,
Human Genome Mapping Project Resource Centre, Sanger
Centre), (2) the theoretical pI and the molecular weight (MW)
of  the  search  result  matching  the  2-DE  position  of  the
corresponding spot, and (3) less than 20% uncleaved peptides
in the matching sequence.
Reverse  Transcriptase  Polymerase  Chain  Reaction  (RT–
PCR): RT–PCR was run to detect whether changes in levels
of crystallins (Table 1) were regulated by changes in mRNA
expression of the associated genes. Total RNA was extracted
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Grand Island, NY) and confirmed using spectrophotometry
and  formaldehyde/agarose  gel  electrophoresis.  To  remove
contaminating genomic DNA, 1 μg of total RNA was treated
with 1 U RNase free DNase I (Promega, Madison, WI) at
37 °C for 30 min and then heated with 1 μl stop solution
(Promega) at 65 °C for 10 min. Subsequently, 0.5 μg of total
RNA  in  each  sample  was  reversely  transcribed  (M-MLV
reverse transcriptase, Promega) using 0.04 μg random primers
(Promega)  in  a  total  volume  of  20  μl  according  to
manufacturer’s instructions.
Due  to  the  lack  of  information  on  crystallin  gene
sequences  for  guinea  pigs,  primers  were  designed  using
mouse αA-crystallin, αB-crystallin, βA3/A1-crystallin, βA4-
crystallin,  and  βB2-crystallin  sequences  in  areas  of  high
interspecies  identity  (Table  1).  Taq  polymerase  (Ex  Taq;
Takara, Dalian, China) and 1 μM primers were used for PCR
amplification.  The  amplification  process  included:  pre-
denaturation for 5 min at 95 °C, followed by 30–35 °C cycles
of denaturation at 95 °C for 30 s, annealing at 59–65 °C for
30 s, extension at 72 °C for 40 s, and a final extension at 72 °C
for  10  min.  The  exact  number  in  cycles  and  annealing
temperature were optimized based on different genes tested
(Table  1).  Equal  volume  (5µl)  of  all  PCR  products  was
electrophorezed on 2% agarose gels containing 2 μl goldview
(SBS genetech, Beijing, China) and then photographed under
ultraviolet illumination. The sizes of the amplified products
were estimated using Marker DL2000 (Takara).
Statistical  analysis:  The  refractive  status  and  axial
components  of  the  form-deprived  eyes  were  statistically
compared to those of the fellow eyes within the same group
at each time point (paired sample t-test, SPSS Version 11.5;
SPSS Inc., 1989-1999, Chicago, IL). These biometric results
were  also  compared  between  different  groups  (one-way
ANOVA with Bonferroni correction, SPSS Version 11.5).
Both  the  intra-group  and  inter-group  differences  were
determined as significant at p<0.05 and highly significant at
p<0.01.
RESULTS
Confirmation  of  phenotypic  changes  induced  by  form
deprivation: Refraction of the guinea pig eyes in all groups
was hyperopic before the experiment (3 weeks of age) with
no significant differences between eyes of the same animals
in refraction and vitreous length (p values were 0.21 and 0.95,
respectively, paired sample t-test, Table 2). The MD eyes
developed myopia of −4.24 D with a greater vitreous length
(0.22 mm) when compared to the fellow eyes over the period
of 7 weeks. In the recovery group, the MD eyes (−3.69 relative
to the fellow eye) developed toward hyperopia after removal
of the facemask with a relative myopia of −2.85 at 4 days of
the recovery process. There was no significant difference in
changes  of  refraction  and  axial  components  between  the
fellow eyes of either the MD group or the recovery group and
the normal control eyes.
Protein profiles of the posterior sclera on 2-DE: The 2-DE
profile  of  all  protein  spots  from  the  posterior  sclera  was
distinct between the MD and recovery or the control eyes
(Figure  1  and  Figure  2).  Twenty-six  spots  were  different
between the MD eyes and normal control eyes in either the
level or location of expression on 2-DE (Table 3). These
included 18 spots with a different level of expression between
the 2 groups where the MD eyes had 3 spots (2 identified: 36,
45) only detected in the MD eyes, 5 spots (4 identified: 3, 42,
181, 232) with a higher expression in the MD eyes, 13 spots
(8 identified: 22, 67, 89, 143, 159, 206, 208, 235) with a lower
expression in the MD eyes, and 5 spots (4 identified: 24, 41,
44, 99) detected only in the normal control eyes (Table 3).
A comparison between the recovery and normal control
eyes showed 3 spots (2 identified: 230, 232) with a higher
expression, 19 spots (7 identified: 10, 19, 30, 38, 43, 141, 166)
with  a  lower  expression  in  the  recovery  eyes,  6  spots  (5
identified: 44, 54, 55, 56, 115) only found in the normal
control eyes and 5 (2 identified: 8, 162) only found in the
recovery eyes (Table 4). The MD eyes (in the MD group) had
5  spots  with  2  (all  identified:  107,  227)  having  a  lower
expression and 3 (all identified: 148, 175, 220) having a higher
expression compared to the recovery eyes (Table 5).
RT–PCR results: In the normal control eyes, the level of
crystallin mRNA expression was highest for αA-crystallin and
αB-crystallin,  followed  by  βA3/A1-,  βA4-  and  βB2-
crystallins (Figure 3). The expression of αA-crystallin mRNA
did not change in the MD eyes, but was higher in the recovery
eyes  when  compared  to  the  normal  control  eyes.  The
expression of αB-crystallin mRNA was lower in both the MD
TABLE 1. SEQUENCE OF PRIMER PAIRS AND LENGTH OF THE AMPLIFIED SEQUENCES BASED ON THE NCBI DATABASE
Gene Forward primer (5′-3′) Reverse primer (5′-3′) Annealing
temperature
(°C)
Cycles Length of
product
(bp)
αA-crystallin AGCCCTTGCCAGCCATCT GCTTGTGCCACCTGCTCTTTA 60 33 220
αB-crystallin AGTTCTTCGGAGAGCACCTGTT TCCTTGGTCCATTCACAGTGAG 64 34 321
βA3/A1-crystallin GCCTGGAGTGGAAGCAAT CTGGATACGGCGAATAGA 59 35 344
βA4-crystallin TGCTGAGTGGAGCGTGGGTAGG GTGGACGTGGAAGGAGCCCACT 65 35 300
βB2-crystallin CCAGAACCTTAACCCCAAGATC GCTGTCCACTTTGATGGGCCTC 65 35 277
GAPDH CGGAGTCAACGGATTTGGTCGTAT AGCCTTCTCCATGGTGGTGAAGAC 65 30 304
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2167and recovery eyes compared to the normal control eyes, and
such a decrease in the recovery eyes was more obvious than
in the MD eyes. The expression of βA3/A1-crystallin mRNA
decreased in the MD eyes but obviously increased in the
recovery eyes when compared to the normal control eyes. The
expression  of  βA4-crystallin  mRNA  in  both  the  MD  and
recovery eyes increased compared to the normal control eyes
and such an increase in the recovery eyes was more obvious
than in the MD eyes. The expression of βB2-crystallin mRNA
decreased in the MD eyes but increased in the recovery eyes
when compared to the normal control eyes.
DISCUSSION
In  this  study,  guinea  pig  eyes  treated  with  monocular
deprivation  facemask  (MDF)  for  a  period  of  7  weeks
developed myopia with a degree of at least −4.24 D and had
a greater increase in vitreous length by 0.22 mm (p<0.001)
when  compared  to  the  fellow  eyes  (Table  2).  This  axial
myopia shifted rapidly toward hyperopia with a slowing of the
growth in the vitreous length within 4 days of removal of the
MDF. These results are similar to those found in previous
studies on the same species [29,30] and confirm that the eyes
used were indeed myopic.
Most of the proteins found to have different levels of
expression  have  not  been  studied  for  their  roles  in  the
development  of  various  axial  components  of  the  eye.
Presumably, any proteins that were upregulated in the MD
eyes  (compared  to  normal  control  eyes)  were  needed  to
facilitate the remodeling of the sclera, and those that were
down-regulated  needed  to  be  dampened  to  allow  scleral
remodeling. Both junctophilin 1 (JP1), a triadic protein that is
thought to be required for normal voltage-gated sarcoplasmic
reticulum  Ca2+  release  [36]  and  GST  subunit  gYc  with
glutathione transferase activity were only detected in the MD
eyes and so were probably very highly upregulated during
MD. Four proteins that were also upregulated in the MD eyes
included adenylate kinase 1 (AK1) that catalyzes conversion
between ATP and AMP molecules and presumably indicates
a  need  for  more  energy  during  scleral  remodelling,  βA4-
Figure  1.  Protein  profiles  of  the
posterior  sclera  on  2-DE.  The  2-DE
distributing profile of the differentially
expressed  protein  spots  from  the
posterior  sclera  distinct  between  the
normal control eyes and the MD eyes or
the  recovery  eyes  (A).  Synthetic  gel
produced from triplicate gels of normal
control  eyes  (B),  the  differentially
expressed  protein  spots  were  framing
labeled.
Figure 2. Dynamic 2-DE profiles of the
differentially expressed proteins in the
posterior sclera of different groups. A:
normal control eyes (NC), B: monocular
deprivation  eyes  (MD),  C:  recovery
eyes.
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2168crystallin which seems to be essential for ocular growth, as
defects  in  the  gene  encoding  this  protein  are  a  cause  of
microphthalmia [37], Fe-S hydrolyase which is also involved
in  energy  production  (possibly  from  NADH),  and  Ca2+-
dependent  activator  protein  for  secretion  2  isoform  b
(CAPS2b)  which  is  a  secretory  vesicle-associated  protein
involved in the release of neurotrophin.
Of the four proteins that were undetected in the MD eyes
as compared to the normal control eyes, and thus heavily
down-regulated  during  formation  of  MD,  adenine
phosphoribosyltransferase (APRT) is an intracellular enzyme
that  contributes  to  formation  of  AMP  by  catalyzing  the
phosphoribosylation  of  adenine,  peroxiredoxin  1  acts  to
protect cells from oxidation, βB2-crystallin is involved in
post-translational  modification  of  proteins,  and  Gnb2l1
(guanine  nucleotide  binding  protein  [G  protein],  beta
polypeptide 2-like 1) mediates signal transduction. Another
eight proteins were down-regulated in the MD eyes: G12v
mutant of human placental Cdc42 GTPase in the GDP form
chain B which is a GTP-binding protein, which involves in
actin assembly, peroxiredoxin 4 which is an anti-oxidative
enzyme  involved  in  gene  transcription  [38],  eukaryotic
translation  initiation  factor  3  subunit  2β  (eIF3–2β)  which
promotes  protein  translation  from  tRNAi  and  mRNA,
macrophage  capping  protein  which  is  an  actin-regulatory
protein, aldehyde dehydrogenase 1 A2 isoform 1 (ALDH1A2)
that  catalyzes  the  synthesis  of  retinoic  acid  in  the  retina,
tubulin α-2 (a cytoskeleton constituent protein) and ATPase
that  catalyzes  the  decomposition  of  ATP  (ATP)  into
adenosine diphosphate (ADP) and free phosphate.
Two proteins were only expressed in the recovery eyes:
ADP-ribosylation  factor  1  (ARF1),  a  small  GTP-binding
protein of the Ras superfamily, which functions as a regulator
of  vesicular  traffic  and  actin  remodeling  and
phosphoglycerate kinase 1 (PGK1) which promotes reduction
of plasmin disulfide bonds leading to angiostatin formation
and inhibition of tumor angiogenesis. Five spot proteins that
were  undetected  in  the  recovery  eyes  and  so  presumably
heavily down-regulated during the recovery process included
the heat-shock protein which involves in cell survival under
hyperthermia  and  other  environmental  stresses,  βB2-
crystallin, the putative DEAD/DEAH box helicase which is
needed  to  unwind  nucleic  acids,  βA3/A1-crystallin,  and
ANXA5 protein which is involved in apoptosis [39]. Seven
TABLE 3. PROTEIN EXPRESSION IN POSTERIOR SCLERA: MD EYES VERSUS NORMAL CONTROL EYES (NC).
Spot no.a Protein level Fold Accession
numberb
Protein description Protein
scorec
3 Up 3.2 gi|61365690 adenylate kinase 1 119
42 Up 8.8 gi|73995384 beta A4-crystallin 101
181 Up 3.5 gi|78195022 Fe-S type hydro-lyases tartrate/fumarate alpha
region
66
232 Up 10.5 gi|68417708 Ca2+-dependent activator protein for secretion 2
isoform b, partial
41
36 Up N/MDd gi|61822969 junctophilin 1, partial 42
45 Up N/MD gi|13936373 glutathione S-transferase subunit gYc 132
22 Down 3.5 gi|4557920 G12v mutant of human placental Cdc42 GTPase in
the GDP form chain B
123
67 Down 3.6 gi|12407849 peroxiredoxin 4 94
89 Down 3.4 gi|32400726 putative alpha-tubulin 97
143 Down 3.6 gi|60813640 eukaryotic translation initiation factor 3 subunit 2
beta
82
159 Down 3.0 gi|73980918 macrophage capping protein (Actin-regulatory
protein CAP-G)
103
206 Down 3.3 gi|25777724 aldehyde dehydrogenase 1A2 isoform 1 91
208 Down 3.2 gi|76618159 tubulin alpha-2 chain 126
235 Down 3.3 gi|78167676 ATPase 52
24 Down eD/NCm gi|1001946 adenine phosphoribosyltransferase 95
41 Down D/NCm gi|55824562 peroxiredoxin 1 179
44 Down D/NCm gi|6978713 beta B2-crystallin 148
99 Down D/NCm gi|52138659 guanine nucleotide binding protein (G protein),
beta polypeptide 2-like 1
221
         aSpot no. is the unique sample spot protein number assigned by the PDQuest software. bAccession number is the MASCOT
      result of MALDI-TOF searched from the NCBInr database. cProtein score was from MALDI-TOF identification. The proteins
      that had a statistically significant protein score of great than 76 (p<0.05) were considered successfully identified. dN/MD, the
      protein spots were newly induced in posterior sclera of the MD eyes. eD/NCm, the protein spots were only detected in posterior
      sclera of the normal control eyes.
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2169other  proteins  were  down-regulated  in  the  recovery  eyes,
including αA-crystallin, αB-crystallin, βA4-crystallin, βA3/
A1-crystallin (in a different position on the gel than the spot
identified above), βB2-crystallin (in a different position on the
gel  than  the  spot  identified  above),  tubulin  α-6  and  actin
cytoskeletal 2 (LPC2). Down-regulation of tubulins (tubulin
α-2  and  tubulin  α-6)  and  CAP-G  (macrophage  capping
protein) may result in a decreased movement of cells and
internal organelles during scleral remodelling.
A comparison between the MD and the recovery eyes
showed that 2 proteins were upregulated in the recovery eyes:
CAPZA2  [capping  protein  (actin  filament)  muscle  Z-line
alpha 2, which regulates the growth of the actin filaments at
the barbed end], and CCT6A3 (T-complex protein 1, zeta
subunit  [TCP-1-zeta;  CCT-zeta;  CCT-zeta-1]  isoform  3)
which  is  a  member  of  the  chaperonin  containing  TCP1
complex (CCT); whereas a putative amidase (an enzyme that
hydrolyzes  amide),  glucose-6-phosphate  dehydrogenase
(G6PD, a cytosolic enzyme in the pentose phosphate pathway
that supplies reducing energy to cells by maintaining the level
of  the  co-enzyme  nicotinamide  adenine  dinucleotide
phosphate [NADPH]), and a hypothetical protein with the spot
matched as beta and gamma cytoplasmic actin were down-
regulated. These differentially expressed proteins belong to
the following functional categories: cytoskeleton, metabolic,
redox, protein degradation, apoptosis and heat shock protein/
chaperones  and  these  categories  suggest  that  the  altered
proteins appear to have multiple roles in scleral remodeling,
increase of extracellular matrix (ECM) and changes in scleral
collagen fibers during the development of and recovery from
form deprivation myopia.
TABLE 4. PROTEIN EXPRESSION IN POSTERIOR SCLERA: RECOVERY EYES VERSUS NORMAL CONTROL EYES (NC).
Spot no.a Protein level Fold Accession
numberb
Protein description Protein
scorec
220 Up 3.0 gi|21614520 glucose-6-phosphate dehydrogenase 90
232 Up 10.5 gi|68417708 Ca2+-dependent activator protein for secretion 2
isoform b, partial
41
8 Up dN/R gi|11968098 ADP-ribosylation factor 1 115
162 Up N/R gi|50513041 phosphoglycerate kinase 1 81
10 Down 4.7 gi|117360 alpha A-crystallin 147
19 Down 3.6 gi|265053 alpha B-crystallin 175
30 Down 3.9 gi|73995384 beta A4-crystallin 107
38 Down 3.5 gi|14285262 beta A3/A1-crystallin 154
43 Down 5.1 gi|299263 beta B2-crystallin 269
141 Down 3.2 gi|73996530 tubulin alpha-6 131
166 Down 3.2 gi|1703112 actin cytoskeletal 2 (LPC2) 81
44 Down eD/NCr gi|6978713 beta B2 crystallin 148
54 Down D/NCr gi|50979116 heat-shock protein 79
55 Down D/NCr gi|27311829 putative DEAD/DEAH box helicase 61
56 Down D/NCr gi|14285262 beta A3/A1-crystallin 103
115 Down D/NCr gi|1006831 ANXA5 protein 101
          aSpot no. is the unique sample spot protein number assigned by the PDQuest software. bAccession number is the MASCOT
       result of MALDI-TOF searched from the NCBInr database. cProtein score was from MALDI-TOF identification. The proteins
       that had a statistically significant protein score of great than 76 (p<0.05) were considered successfully identified. dN/R, the
       protein spots were newly induced in posterior sclera of the recovery eyes. eD/NCr, the protein spots were only detected in posterior
       sclera of the normal control eyes.
TABLE 5. PROTEIN EXPRESSION IN POSTERIOR SCLERA: MD EYES VERSUS RECOVERY EYES.
Spot no.a Protein level Fold Accession
numberb
Protein description Protein
Scorec
107 Up 3 gi|68270947 capping protein (actin filament) muscle Z-line alpha 2 101
227 Up 3.7 gi|73957579 similar to T-complex protein 1, zeta subunit (TCP-1-zeta)
(CCT-zeta) (CCT-zeta-1) isoform 3
95
148 Down 3.5 gi|54016803 putative amidase [Nocardia farcinica IFM 10152] 72
175 Down 9.5 gi|73964667 hypothetical protein XP_533132 210
220 Down 3.5 gi|21614520 glucose-6-phosphate dehydrogenase 90
        aSpot no. is the unique sample spot protein number assigned by the PDQuest software. bAccession number is the MASCOT
     result of MALDI-TOF searched from the NCBInr database. cProtein score was from MALDI-TOF identification. The proteins
     that had a statistically significant protein score of great than 76 (p<0.05) were considered successfully identified.
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2170Crystallins are major structural proteins in the lens and
belong to the small heat-shock protein family which control
protein folding in the endoplasmic reticulum and subsequent
intracellular trafficking [40]. In spite of their diversity, many
crystallins play a role in essential developmental processes
such as cell elongation and inhibition of cell apoptosis [41].
In the retina, the expression of members of α-, β- and  γ-
crystallin gene families are upregulated under stress, induced
by intense light exposure or retinal tearing [42-44]. However,
the  precise  organization  and  biologic  functions  of  the
crystallins in the sclera are not known. In this study, crystallins
were located between pI 3–10 which is similar to those from
a previous 2-DE study of chickens [45]. Crystallins including
subtypes of αA-, αB-, βA3/A1-, βA4- and βB2-crystalin were
detected at both mRNA (RT–PCR) and functional levels (2-
DE)  in  the  posterior  sclera  of  the  guinea  pigs  after  form
deprivation and the recovery.
For the α-crystallins, two α-crystallin polypeptides (αA
and αB) are molecular chaperones that can protect proteins
(e.g., β-crystallins) from thermal aggregation [46-49], with
αB-crystallin  being  more  efficient  than  αA-crystallin  in
preventing the aggregation of proteins [48,49]. The αA and
αB subunits share approximately 60% amino acid sequence
identity and account for 20% to 30% of the lens total proteins
Figure  3.  Expression  of  αA-,  αB-,  βA3/A1-,  βA4-  and  βB2-
crystallins mRNA in posterior sclera of the guinea pigs in different
groups.  normal  control  eyes  (NC),  monocular  deprivation  eyes
(MD), recovery eyes. GAPDH was used as a loading control.
[50].  They  exist  as  heteromers  that  can  undergo  subunit
exchange  [51].  The  α-crystallins  may  be  involved  in  the
regulation of cellular growth and genomic stability [52-54]. It
has been found that αA-, βA3/A1-, βB1-, and βB2-crystallin
mRNAs  are  upregulated  in  retina-RPE-choroid  of  form-
deprived  chicken  eyes  [55].  Retinal  expression  of  αB-
crystallin mRNA elevates in form-deprived eyes and remains
elevated with only a slight return to control levels after the re-
exposure of the eye to normal visual conditions in chickens
[56,57]. These results indicate that members of the crystallin
family do play a role in the development of form deprivation
myopia.
In this present study, the expression of αB-crystallin in
the posterior sclera was down-regulated in the myopic and
recovery eyes at both protein and mRNA levels compared to
the normal control eyes (Table 6). This is different to previous
studies [56,57] where αB-crystallin mRNA was upregulated
in retina of the myopic and recovery eyes in chickens. This
may be due to the use of different species or different tissues
for the recovery of the mRNA. The level of αA-crystallin
mRNA or protein expression did not obviously differ in the
myopic  eyes  compared  to  the  normal  control  eyes.
Furthermore, αA-crystallin protein in the recovery eyes was
down-regulated  although  the  αA-crystallin  mRNA  is
upregulated. A similar mismatch in expression of βA3/A1-,
βA4- and βB2-crystallins between 2-DE and PCR occurred in
the recovery eyes. It is possible that these mRNA changes are
a prelude to protein changes that only manifest, or at least can
be detected to change, after 4 days of recovery.
This present study focused on changes in protein profiles
of posterior sclera of guinea pigs, whereas Frost and Norton
[24] examined the entire sclera of tree shrews. An inherent
variability across the gels might have limited the detection of
biologic variations between groups, although Diz [58] has
found that pooled samples matched the mean expression of
the individuals making up the pool for the majority of proteins.
Hence, results in the present study are likely to provide a good
survey of the number of proteins whose levels change during
form  deprivation  myopia  and  the  subsequent  recovery.
Previous  studies  have  demonstrated  changes  to  other
extracellular  matrix  proteins  including  collagen  I  and
glucosaminoglycan [17,24]. However, the present study did
not identify changes to these proteins using 2-DE. This may
have been due to the cut-off of threefold in protein expression
before spots on the 2-DE were identified, and changes to these
proteins not reaching this cut off.
In summary, this study adopted a gel-based proteomic
approach to probe the serially changed proteins in posterior
sclera of guinea pigs during development of form deprivation
myopia and recovery. In general, changes in crystallin protein
levels were consistent with those in mRNA levels during the
development of FDM. However, changes in most crystallin
protein  levels  were  mismatched  with  their  mRNA  levels
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2171during  the  recovery  stage.  Furthermore,  the  absolute
quantities of mRNA expression for the proteins isolated by 2-
DE may not be accurate without real time PCR. However, the
main interest for this study was to investigate the difference
in  levels of  protein  expression  between different experi-
mental groups rather than the absolute quantity for the in-
dividual  proteins.  Further proteomic  analyses will  be fo-
cused on the  functional  role of  the differentially expressed
proteins  during  development  of  the  experimental  myopia
and recovery.
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